Dr. Andrea M. Harangozo, MD

Dr. Harangozo practices at Pulmonary And Intensive Care Specialists Of New Jersey in East Brunswick, New Jersey.

Dr. Harangozo's NPI, 1982793253, was assigned on October 12, 2006. Dr. Harangozo graduated from New York University School of Medicine in 1984. Dr. Harangozo holds New Jersey license MA48480.

Dr. Harangozo's primary practice is Pulmonary and Intensive Care Specialists of New Jersey, at 593 Cranbury Rd, East Brunswick, NJ 08816. The practice phone is (732) 613-8880.

Dr. Harangozo's primary practice is Pulmonary And Intensive Care Specialists Of New Jersey in East Brunswick, New Jersey. Dr. Harangozo is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Robert Wood Johnson Physician Enterprise. Dmand AI also links Dr. Harangozo to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harangozo practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Harangozo's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Harangozo is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Harangozo is licensed in New Jersey.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, lung disease: COPD, asthma or bronchitis and pneumonia among the conditions Dr. Harangozo treats.

CMS data shows 2,042 Medicare services from Dr. Harangozo across 19 procedure codes in 2024, for 551 Medicare patients. Medicare paid $173,077 for them.

CMS counts 551 Medicare patients who saw Dr. Harangozo in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harangozo's median patient age at 71, with 56% women.

In 2024, Dr. Harangozo wrote 1,270 Medicare Part D claims for 312 patients. 51% of them were for generic drugs. CMS names the drug for 1,091 of them, across 27 drugs with 11 or more claims each, at $392,195 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Harangozo for performance year 2024, reported through an alternative payment model (APM). Dr. Harangozo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harangozo as offering telehealth.

Dmand AI links 2 papers to Dr. Harangozo.

CMS Open Payments shows 84 general payments to Dr. Harangozo from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $362.

Dmand AI lists 15 awards for Dr. Harangozo, most recently NJ.com Top Doctors in 2019.

Dr. Harangozo graduated from New York University School of Medicine in 1984.

Dr. Harangozo is in network with 10 carriers, including Aetna, Elevance and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.